Topics

FDA recalls ranitidine medicines over potential cancer causing impurity

13:37 EDT 2 Oct 2019 | British Medical Journal

The US Food and Drug Administration has asked doctors and patients to return certain batches of over-the-counter ranitidine tablets (75 mg and 150 mg), after low levels of the probable human...

Original Article: FDA recalls ranitidine medicines over potential cancer causing impurity

NEXT ARTICLE

More From BioPortfolio on "FDA recalls ranitidine medicines over potential cancer causing impurity"

Quick Search